These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2449136)

  • 1. [Clinical phase II study of K-18 in cancer of the digestive organs].
    Urushizaki I; Mogi Y; Kohgo Y; Onodera Y; Niitsu Y; Koyama R; Itaya H; Nakazawa O; Saijo N; Matsuda M
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):361-4. PubMed ID: 2449136
    [No Abstract]   [Full Text] [Related]  

  • 2. [5-FU concentration in portal blood after oral administration of 1-hexylcarbamoyl-5-fluorouracil (HCFU)].
    Seo Y; Hara Y; Furusawa M; Nakane H; Saeki K; Tsujitani S; Sonoda T; Nohtsuka T; Kameda K; Tomoda H
    Gan To Kagaku Ryoho; 1988 May; 15(5):1803-5. PubMed ID: 2453163
    [No Abstract]   [Full Text] [Related]  

  • 3. [A study of the antineoplastic activity of K18].
    Nakatani K; Miyagi N; Ezaki T; Sugisaki T; Sakamoto K; Watanabe A; Fujioka T; Shiratori T
    Gan To Kagaku Ryoho; 1986 May; 13(5):1985-91. PubMed ID: 2423038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of multiple myeloma responding very well to the combination of K18 with prednisolone].
    Ishioka C; Kanamaru R; Sato T; Konishi Y; Himori T; Mimata Y; Wakui A
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1164-6. PubMed ID: 2436580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of amsacrine in patients with hepatoma: a Cancer and Leukemia Group B study.
    Amrein PC; Richards F; Coleman M; Poulin RF; Holland JF; Weinberg V; Perry M
    Cancer Treat Rep; 1984 Jun; 68(6):923-4. PubMed ID: 6329510
    [No Abstract]   [Full Text] [Related]  

  • 6. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
    Kimura K
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1324-31. PubMed ID: 6329104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of K-18 and concomitant hyperthermia for treatment of Lewis lung carcinoma in mice.
    Tamada R; Kai H; Sugimachi K; Takenaka K; Hiramoto Y; Inokuchi K
    Jpn J Surg; 1985 Mar; 15(2):173-6. PubMed ID: 2409315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination of chemotherapy and surgical treatment of malignant tumors].
    Shabanov AN; Kizhaev VI; Dorokhin IF; Zogorianskiĭ IA
    Vopr Onkol; 1967; 13(3):86-91. PubMed ID: 4177539
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical effects of K-18 (IgG-melphalan) in hypoplastic leukemia: a case report].
    Takahashi I; Ohmoto E; Nakada H; Inagaki N; Nonaka K; Takeuchi M; Osada K; Tsurumi N; Uchida K; Yorimitsu S
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):159-62. PubMed ID: 2447835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical trial of a new antiblastic drug, ortho-merphalan (Merophan). I. Effects in patients with gastric carcinoma in advanced stage].
    Gardini GF; Peretti S; Castellari S; Maltoni C
    Cancro; 1968; 21(2):91-9. PubMed ID: 4888046
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma exchange for malignant neoplasms--immunological consideration].
    Maeda K; Matsumoto S; Ito N; Takeuchi S; Omi N
    Rinsho Ketsueki; 1982 Oct; 23(10):1608-12. PubMed ID: 6296481
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II evaluation of mitoxantrone in advanced carcinoma of the stomach: a Southeastern Cancer Study Group Trial.
    DeSimone PA; Gams R; Birch R
    Cancer Treat Rep; 1986 Aug; 70(8):1043-4. PubMed ID: 3524836
    [No Abstract]   [Full Text] [Related]  

  • 13. [What can be done for patients with cancer of the digestive tract in 2003? Guidelines of the Francophone Federation of Digestive Tract Cancerology--part II].
    Conseil Scientifique de La FFCD
    Gastroenterol Clin Biol; 2003 Jan; 27(1):43-58. PubMed ID: 12594364
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative studies on the therapeutic effects of transcatheter arterial chemo-embolization and intra-arterial one-shot infusion of anticancer drugs for unresectable hepatocellular carcinoma].
    Imaeda T; Yamawaki Y; Hirota K; Suzuki M; Goto H; Seki M; Asada S; Sone Y; Iinuma G; Doi H
    Rinsho Hoshasen; 1987 Jul; 32(7):807-13. PubMed ID: 2824883
    [No Abstract]   [Full Text] [Related]  

  • 15. [The current status of chemo- or immunotherapy of gastrointestinal tumors].
    Schmidt M; Gropp C; Martini GA
    Internist (Berl); 1978 Dec; 19(12):692-9. PubMed ID: 217849
    [No Abstract]   [Full Text] [Related]  

  • 16. [Congress of the American Society of Clinical Oncology].
    André T
    J Chir (Paris); 2002 Oct; 139(5):300-3. PubMed ID: 12410132
    [No Abstract]   [Full Text] [Related]  

  • 17. [Late phase II study of YNK-01 (an oral prodrug of cytarabine) for hepatocellular carcinoma].
    Suto T; Yoshida Y; Sakata Y; Ono T; Yoshida T; Yamada N; Chida N; Oohira H
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1933-8. PubMed ID: 9797816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is there a place for arterial chemoembolization of the liver in the treatment for hepatocellular carcinoma?].
    Trinchet JC; Mathieu D; Beaugrand M
    Gastroenterol Clin Biol; 1995 Dec; 19(12):967-9. PubMed ID: 8729406
    [No Abstract]   [Full Text] [Related]  

  • 19. [A phase II study of ranomustine (MCNU) tablets in patients with gastrointestinal cancer--by cooperative study group].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2420-6. PubMed ID: 6497400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arterial infusion chemotherapy and embolization in unresectable hepatocellular carcinoma using an intraarterial catheter].
    Tanada M; Soga H; Kurita K; Takiyama W; Saeki H; Takashima S; Satoh G; Wada T; Jinno K; Tokuyama K
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2470-2. PubMed ID: 2843111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.